Recruiting and Developing Specialized Talent
First written in FY2018. 3 of 8 entries say "Reframed", first in FY2021. Latest entry: FY2026.
- FY2026ReframedAnnual report
「The Group positions human capital as an important management resource for enhancing corporate value and is considering the following areas as priority themes. ・Technological innovation through the development and mobilization of highly specialized personnel ・Development of DX personnel who use data and AI ・Building an organization that autonomously practices quality and compliance ・Well-being management in which diverse personnel can thrive」
The Group is reorganizing its existing training, recruitment and “thinking and acting” initiatives into 4 priority themes based on its positioning of human capital as an important management resource. - 2026-08-07ReframedFinancial Results Presentation
「Well-being management」
The company presents its existing recruitment, training and talent development initiatives as well-being management, including efforts to strengthen its responsible management as a pharmaceutical manufacturer and marketer through investment in people and education. - FY2025Articulation of the human resources development conceptAnnual report
「We are working to foster employee growth based on the concept of “the ability to learn and think independently, exercise imagination, and overcome challenges,” or “thinking and action.” In addition to training for executives and managers, online training for general employees has continued from the previous fiscal year.」
In addition to the existing training and skills-mapping policies, the company has articulated its approach to employee development through the concept of “thinking and acting” and continues to provide online training for general employees. - FY2024AdvancedAnnual report
「Accordingly, we will continue to recruit experienced personnel actively and, under the new personnel system introduced in the fiscal year ending June 2024, actively promote employees based on new evaluation criteria without regard to their attributes. We also recognize that more active internal communication is necessary to improve employee engagement and productivity, and will actively implement measures to promote vertical communication within departments and cross-functional communication between departments.」
In addition to its existing training and recruitment measures, the company introduced a new personnel system in the fiscal year ending June 2024 and identified promotions under new evaluation criteria and the activation of communication within and between departments as specific human resources measures. - FY2023AdvancedAnnual report
「In the fiscal year ended June 2023, in addition to continuing training for managers and executives, we introduced online training for general employees. Going forward, we aim to establish a medium- to long-term human resources development program by clarifying the skills map and further enhancing education and training.」
In addition to continuing training for managers and executives, the company introduced online training for general employees and identified clarifying the skills map and establishing a medium- to long-term human resources development program as its next measures. - FY2021ReframedAnnual report
「We are formulating workforce plans in line with business expansion, recruiting without regard to gender, and providing employee training. We are also working to reduce overtime by further strengthening working-hours management through measures including improving meeting efficiency.」
The scope of human resources measures has expanded to include the recruitment and development of specialists in high-potency pharmaceutical products and other areas, gender-neutral recruitment, working-hours management, overtime reduction, and work-life balance. - FY2019RestatedAnnual report
「As the company promotes its contract manufacturing business for high-potency injectable products, it will be important to recruit and develop personnel with knowledge of or manufacturing experience in high-potency pharmaceutical products, which require advanced expertise to handle. Accordingly, we will formulate workforce plans in line with business expansion and provide employee training.」
The recruitment and development of specialists in high-potency pharmaceutical products remains an issue. - FY2018First statedAnnual report
「We will formulate workforce plans in line with business expansion and provide employee training.」
Measures targeting personnel specializing in analysis, research and development, manufacturing, particularly high-potency pharmaceutical products.